AI generated
Aug 18, 2026, 19:46
Lesley Van Wyk: ANA Testing – From Screening to Interpretation
Lesley Van Wyk, Laboratory Manager at National Health Laboratory Service, shared a post on LinkedIn:
“ANA Testing: From Screening to Interpretation
ANA is a key screening test used in autoimmune disease evaluation.
Learn about ANA by IFA, titers, common patterns, follow-up tests, specimen requirements, result interpretation, false results, and clinical significance.”
Stay updated with Hemostasis Today.
-
Aug 18, 2026, 19:49Make the Most of Your Summer and Catch Up on Gene Therapy – EAHAD
-
Aug 18, 2026, 19:45Factor IV – The ‘Coagulation Factor’ That Isn’t a Protein – ICHCC
-
Aug 18, 2026, 19:42Melanie Jay: What Should Behavioral Support Look Like Alongside Obesity Medications?
-
Aug 18, 2026, 19:40Subodh Verma: Tirzepatide Improves Multiple Cardiovascular Risk Pathways
-
Aug 18, 2026, 19:37Boby Varkey Maramattom: Thrombolysis in Acute Ischemic Stroke With an Unruptured Aneurysm
-
Aug 18, 2026, 19:35Kelly Anderson: Factor XIa Inhibition for Secondary Stroke Prevention
-
Aug 18, 2026, 19:33Nebil Youssef: Deaths in Custody Raise New Questions for Syria’s Government
-
Aug 18, 2026, 19:32Ihab Suliman: A Snake Venom Helping Diagnose an Autoimmune Clotting Disorder?
-
Aug 18, 2026, 16:57New Insights Into Hemophilic Arthropathy – CRH French Reference Center for Hemophilia Lyon